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Guy et al. (1974) reported that when skin was
exposed to infra-red radiation or when hot packs
were applied, the surface temperatures attained fell
progressively throughout treatment. Gibbs (1983),
using microwave heating, also demonstrated a
decrease in temperature with time which appeared
to extend several centimetres into the tissue. These
changes were attributed to an increase in the local
blood flow in response to the heat stimulus. In this
centre local hyperthermia treatment has been used
to palliate advanced cancer in axillary nodes. RF
(13.56 MHz) energy was applied using capacitive
coupling via flexible pillows perfused with cooled
6% saline (Griffiths et al., 1983a). Temperatures in
tumour and normal tissue were monitored with
multi-junction, copper-constantan thermocouples
inserted into nylon catheters implanted in the tissue
by the standard technique for iridium implants
(Paine, 1972). Temperature measurements were
intrinsically accurate to + 0.1°C. Twelve patients
were treated on a total of 29 occasions, and during
treatment similar decreases in temperature were
observed.
These observations are summarised in Table I.
On eighl occasions the temperature indicated by at
least one thermocouple sensor fell whilst the RF
power was maintained at a constant value or when
it was slightly increased. For each treatment the
data from the thermocouple junction which
indicated the largest fall in temperature are shown,
although higher absolute values of temperature
were measured elsewhere in the tissue. The data for
Patient 1 are given in more detail in Figure 1.
Signals are shown from three thermocouple
junctions A, B and C, situated - 10, 30 and 60mm
from the anterior skin surface, and all located
under the treatment area. During a planned h
treatment the RF power is briefly switched off
several times to make small adjustments for patient
comfort and cooling pillow alignment. The total
time in the treatment situation rarely exceeds l1 h.
The traces in Figure 1 begin when the power was
switched on again having been switched off for
-6min. The power was increased to 250W and
then held constant until being switched off finally.
Junctions B and C showed a gradual rise in
temperature from approximately 37.5°C to 39.0°C.
Because of its proximity to the cooled skin surface
junction A initially indicated a lower temperature,
33.8°C, and showed a more rapid temperature rise
when the RF power was switched on due to the
higher specific absorption rate (SAR) near the
electrode, reaching a maximum of 40.9°C. Although
the power was held constant the temperature then
fell by 1.4°C by the end of treatment.
The drop in temperature cannot be explained by
a drift in the temperature monitoring system
because of its large magnitude, the drift in the
system being -0.1 Ch-1. In addition, none of the
other traces shows a corresponding drop in
temperature. A decrease in the power output of the
RF generator can also be eliminated since this is
monitored carefully and held constant to better
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Figure 1 Detailed temperature measurements for
Patient 1 (Table I) from thermocouple junctions A, B
and C situated -10, 30 and 60mm deep in the tissue
respectively. Trace D gives the temperature of the
saline in the anterior cooling pillow.
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Table I Changes in tissue temperature for constant RF power
input
T1 T2 T1-JT2 At d AToral
Patient (0C) (°C) (OC) (mins) (mm) (°C)
1. Rec. Ca. breast 40.9 39.5 1.4 12 10+5 0.6
2. Rec. Ca. breast 39.9 39.4 0.5 8 10+5 0.3
3. Rec. Ca. breast* 43.9 42.6 1.3 27 10+5 0.3
* 41.5 40.5 1.0 54 10+5 0.6
* 41.5 40.3 1.2 47 10+5 0.0
4. Rec. Ca. breast 39.4 38.0 1.4 9 10+5 0.0
5. Melanoma 42.6 41.9 0.7 28 45+5 -0.2
t 39.0 38.5 0.5 43 45+5 0.1
*Skin temperature held at 41.5°C
tRF power increased from 200 to 240W
T1 is the maximum temperature recorded during the heating
period. T2 is the value to which the temperature fell whilst the
power delivered to the patient was constant. At is the time
interval over which the fall in temperature T1-T2 occurred. d
is the depth of the thermocouple junction below the skin
surface. ATor,a is the difference between the patient's oral
temperature when the fall in tissue temperature occurred and
that measured at the beginning of the treatment.
than 5%. A shift in the position of one of the
cooling pillows due to movement of the patient can
alter the SAR distribution within the tissue giving
rise to changes in the recorded temperatures.
However, this invariably results in an RF
impedance mismatch which is immediately noted
and corrected, and did not occur on this occasion.
A change in cooling pillow saline temperature can
influence the temperature of the tissues close to the
surface by thermal conduction. However, it can be
seen from trace D in Figure 1 that the saline
temperature was either increasing or almost
constant when trace A was decreasing. These
changes would not produce the observed fall in
tissue temperature. In fact, since the saline cooling
system is not thermostatted, the saline temperature
rises as the heat removal workload from the
superficial tissue increases. The temperature
changes in trace A are therefore reflected in trace D
with a time delay.
Decreases in tissue temperature during periods of
constant power delivered to the patient have been
observed on 8/29 occasions (36%) when RF
hyperthermia was used to palliate cancer. The fall
in temperature occurred after a time ranging from
47 to 90min of the treatment. These changes may
be interpreted as cooling of the tissue at a
particular depth due to increased blood flow
following vasodilatation. On five of the occasions a
rise in oral temperature was recorded. Patients 1
and 2 showed visible signs of generalised skin
vasodilatation and sweating. It is important to
know the frequency with which a fall in tissue
temperature occurs during the clinical application
of hyperthermia as a treatment for cancer.
As in all cancer treatment modalities, normal
tissue tolerance is the factor limiting the dose which
can be delivered to the tumour. Vasodilatation is a
natural mechanism which acts to protect normal
tissue. If it occurs, it may be possible by increasing
the applied RF power, to achieve a higher tumour
temperature before normal tissue tolerance is
exceeded, thereby increasing the Therapeutic Gain
of the treatment. On seven of the occasions shown
in Table I the fall in temperature was recorded at a
depth of - IOmm in the tissue. It was difficult to
ascertain whether the thermocouple junctions were
in tumour or normal tissue because of the diffuse
nature of the tumour. The data for Patient 5,
however, indicate that the temperature deeper in
the tissue may also be affected by changes in the
local blood flow. In this case the thermocouple
junction was situated approximately at the centre of
a tumour mass palpably several centimetres in
diameter. Since vasodilatation appears not to occur
on all occasions, these results emphasise the
importance of continuous temperature monitoring
in both tumour and normal tissue during every
treatment. The thermocouple system used with
these patients was developed specifically to allow
monitoring of temperature continuously at multiple
points within the tissue during RF hyperthermia,
and has been described elsewhere (Griffiths et al.,
1983b).PHYSIOLOGICAL EFFECT DURING RF HYPERTHERMIA 803
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